- Veterinary corticosteroids, used for managing inflammation, allergies, and autoimmune conditions in animals, are becoming essential components of modern veterinary therapeutics across both companion and livestock sectors due to their rapid efficacy, broad-spectrum applications, and adaptability in various formulations
- The growing demand for veterinary corticosteroids is primarily fueled by the rising pet ownership worldwide, increasing incidence of chronic inflammatory conditions, and the expansion of livestock farming requiring preventive and therapeutic care
- North America dominated the veterinary corticosteroids market with the largest revenue share of 39.7% in 2024, supported by advanced veterinary healthcare infrastructure, high pet care expenditure, and strong awareness among pet owners, particularly in the U.S. where demand for glucocorticoids in companion animals remains significant.
- Asia-Pacific is projected to be the fastest growing region during the forecast period due to rising livestock populations, increasing veterinary service accessibility, and greater adoption of pet healthcare products in countries such as China and India.
- The glucocorticoids segment led the veterinary corticosteroids market with the highest market share of 75.5% in 2024, driven by its versatility, strong anti-inflammatory action, and widespread use in both acute and chronic animal health conditions
